Market cap
$46,269 Mln
Revenue (TTM)
$2,909 Mln
P/E Ratio
--
P/B Ratio
25
Div. Yield
0 %
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
46,269 | 102,409 | 96,159 | 29,951 | 28,416 |
Revenue ($ Mln) |
2,909 | 420,614 | 78,701 | 14,595 | 11,841 |
Net Profit ($ Mln) |
-164.71 | 11,053.00 | 6,776.00 | 1,004.00 | 1,129.00 |
Net Margin (%) |
-5.66 | 2.63 | 8.61 | 6.88 | 9.53 |
RoE (%) |
-9.04 | 13.98 | -- | 11.41 | 14.38 |
Price to Earnings |
-- | 9.30 | 15.80 | 30.23 | 25.73 |
Price-To-Book |
25.05 | 1.29 | 291.34 | 2.94 | 3.73 |
Income Statement ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2,908.88 | 420,614.00 | 78,701.00 | 14,594.50 | 11,841.00 |
|
Cost of Revenue
|
1,011.95 | 360,776.00 | 61,631.00 | 10,367.40 | 7,920.00 |
|
Gross Profit
|
1,495.49 | 55,362.00 | 31,374.00 | 4,012.50 | 3,665.00 |
|
Operating Expenses
|
2,157.34 | 44,777.00 | 55,312.00 | 2,725.00 | 2,198.00 |
|
Operating Profit (EBIT)
|
-260.42 | 15,061.00 | 12,072.00 | 1,502.10 | 1,723.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-224.98 | 12,118.00 | 9,823.00 | 1,224.70 | 1,499.00 |
|
Provision for Tax
|
-60.26 | 1,086.00 | 2,024.00 | 219.60 | 342.00 |
|
Profit after Tax (Net Income)
|
-164.71 | 11,053.00 | 6,776.00 | 1,004.00 | 1,129.00 |
|
Minority Interest
|
0.00 | -9.00 | -1,023.00 | -1.10 | -51.00 |
|
Consolidated Profit
|
0.00 | 2,943.00 | 1,878.00 | 164.70 | 245.00 |
Liabilities ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,869.56 | 80,497.00 | -8,077.00 | 8,847.80 | 7,632.00 |
|
Minority Interest
|
0.00 | -9.00 | -1,023.00 | -1.10 | -51.00 |
|
Non-Current Liabilities
|
265.96 | 84,289.00 | 48,272.00 | 7,241.10 | 7,356.00 |
|
Current Liabilities
|
612.90 | 93,097.00 | 19,779.00 | 2,819.60 | 1,834.00 |
|
Total Liabilities
|
2,398.34 | 253,538.00 | 60,720.00 | 18,392.70 | 16,225.00 |
Assets ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,025.80 | 178,683.00 | 47,233.00 | 14,958.40 | 14,104.00 |
|
Current Assets
|
1,722.61 | 79,392.00 | 16,219.00 | 3,966.20 | 3,117.00 |
|
Total Assets
|
2,398.34 | 253,538.00 | 60,720.00 | 18,392.70 | 16,225.00 |
|
Total Debt*
|
238.84 | 75,297.00 | 52,426.00 | 6,775.90 | 6,285.00 |
|
Net Current Assets
|
1,109.72 | -13,705.00 | -3,560.00 | 1,146.60 | 1,283.00 |
Cashflow ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
215.30 | 10,639.00 | 12,636.00 | 1,640.50 | 1,886.00 |
|
Cash Flow from Investing Activities
|
-132.21 | -5,871.00 | -4,988.00 | -1,194.00 | -631.00 |
|
Cash from Financing Activities
|
47.46 | -4,940.00 | -8,550.00 | -1,457.00 | -1,388.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-12.58 | 1.13 | 14.79 | 5.75 | 7.10 |
|
ROE (%)
|
-9.04 | 13.98 | -612.27 | 11.41 | 14.38 |
|
ROA (%)
|
-5.86 | 3.16 | 8.42 | 4.71 | 6.04 |
|
EBIT Margin (%)
|
-7.46 | 3.61 | 15.45 | 9.93 | 14.51 |
|
Net Margin (%)
|
-5.66 | 2.63 | 8.61 | 6.88 | 9.53 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
37.43 | 6.73 | 5.82 | 6.02 | 9.13 |
|
EBIT Growth (%)
|
29.00 | 153.30 | 5.76 | 8.72 | 8.87 |
|
Net Profit Growth (%)
|
46.73 | 2,256.72 | 6.81 | 17.40 | 16.51 |
|
EPS Growth (%)
|
50.61 | 2,152.97 | 17.46 | 19.83 | 17.55 |
|
Book Value Growth (%)
|
42.17 | 8.50 | -317.59 | 4.35 | 6.09 |
Valuation Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-150.47 | 57.32 | 15.88 | 23.81 | 19.59 |
|
Price / Book Value
|
18.29 | 1.29 | 291.34 | 2.94 | 3.73 |
|
Dividend Yield (%)
|
-- | 3.27 | 0.64 | 0.78 | 1.30 |
|
EV/EBITDA
|
-138.12 | 8.72 | 9.05 | 16.66 | 15.16 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.71 | -5.25 | 0.59 | 0.73 |
|
Short term debt to equity ratio
|
0.05 | 0.07 | -1.00 | 0.09 | 0.03 |
|
Current Ratio
|
2.81 | 0.85 | 0.82 | 1.41 | 1.70 |
|
Quick Ratio
|
2.66 | 0.66 | 0.74 | 1.22 | 1.58 |
|
Interest Coverage
|
-21.88 | 4.95 | 5.16 | 6.32 | 6.90 |
Operating Efficiency Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Labcorp Holdings | Quest Diagnostics (DGX) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
16.20 | 10.00 | 14.62 | 17.53 | 14.46 |
|
Asset Turnover
|
1.03 | 1.20 | 0.98 | 0.68 | 0.63 |
|
Receivable days
|
48.36 | 34.63 | 52.22 | 57.04 | 44.88 |
|
Inventory Days
|
25.50 | 19.68 | 14.00 | 18.89 | 9.34 |
|
Payable days
|
15.34 | 17.66 | 36.90 | 31.54 | 46.76 |
|
Cash Conversion Cycle
|
58.52 | 36.65 | 29.32 | 44.39 | 7.47 |